PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
4BASEBIO UK SOCIETAS (4BB.L)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINGB00BMCLYF79
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap£199.76M
EPS (TTM)-£0.62
Total Revenue (TTM)£268.00K
Gross Profit (TTM)-£199.00K
EBITDA (TTM)-£3.39M
Year Range£492.00 - £1,820.00
Target Price£1,800.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


4BASEBIO UK SOCIETAS

Performance

Performance Chart

The chart shows the growth of an initial investment of £10,000 in 4BASEBIO UK SOCIETAS, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%FebruaryMarchAprilMayJuneJuly
362.22%
55.65%
4BB.L (4BASEBIO UK SOCIETAS)
Benchmark (^GSPC)

S&P 500

Returns By Period

4BASEBIO UK SOCIETAS had a return of 129.41% year-to-date (YTD) and 171.30% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date129.41%18.12%
1 month1.96%5.09%
6 months122.86%17.78%
1 year171.30%26.91%
5 years (annualized)N/A13.37%
10 years (annualized)N/A11.12%

Monthly Returns

The table below presents the monthly returns of 4BB.L, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-1.47%21.64%17.79%11.46%30.84%10.00%129.41%
20233.52%-2.72%-8.39%-2.29%-11.72%1.77%-2.61%9.82%-9.35%-7.62%9.71%20.35%-4.23%
2022-8.94%-1.79%-5.45%5.77%-14.55%-9.57%32.35%4.44%-4.26%-2.22%27.27%1.43%15.45%
202111.11%-10.67%7.46%6.25%19.48%9.41%44.00%5.56%-6.58%-9.15%-4.65%82.22%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of 4BB.L is 99, placing it in the top 1% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of 4BB.L is 9999
4BB.L (4BASEBIO UK SOCIETAS)
The Sharpe Ratio Rank of 4BB.L is 100100Sharpe Ratio Rank
The Sortino Ratio Rank of 4BB.L is 9898Sortino Ratio Rank
The Omega Ratio Rank of 4BB.L is 9999Omega Ratio Rank
The Calmar Ratio Rank of 4BB.L is 9898Calmar Ratio Rank
The Martin Ratio Rank of 4BB.L is 9898Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for 4BASEBIO UK SOCIETAS (4BB.L) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


4BB.L
Sharpe ratio
The chart of Sharpe ratio for 4BB.L, currently valued at 4.51, compared to the broader market-2.00-1.000.001.002.003.004.51
Sortino ratio
The chart of Sortino ratio for 4BB.L, currently valued at 4.76, compared to the broader market-4.00-2.000.002.004.004.76
Omega ratio
The chart of Omega ratio for 4BB.L, currently valued at 2.04, compared to the broader market0.501.001.502.002.04
Calmar ratio
The chart of Calmar ratio for 4BB.L, currently valued at 5.23, compared to the broader market0.002.004.006.005.23
Martin ratio
The chart of Martin ratio for 4BB.L, currently valued at 19.69, compared to the broader market-10.000.0010.0020.0019.69
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.49, compared to the broader market-2.00-1.000.001.002.003.002.49
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.48, compared to the broader market-4.00-2.000.002.004.003.48
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.44, compared to the broader market0.501.001.502.001.44
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.96, compared to the broader market0.002.004.006.001.96
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 9.23, compared to the broader market-10.000.0010.0020.009.23

Sharpe Ratio

The current 4BASEBIO UK SOCIETAS Sharpe ratio is 4.51. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of 4BASEBIO UK SOCIETAS with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.006.00FebruaryMarchAprilMayJuneJuly
4.51
2.26
4BB.L (4BASEBIO UK SOCIETAS)
Benchmark (^GSPC)

Dividends

Dividend History


4BASEBIO UK SOCIETAS doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-15.00%-10.00%-5.00%0.00%FebruaryMarchAprilMayJuneJuly
-14.29%
0
4BB.L (4BASEBIO UK SOCIETAS)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the 4BASEBIO UK SOCIETAS. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 4BASEBIO UK SOCIETAS was 47.71%, occurring on Jul 13, 2022. Recovery took 410 trading sessions.

The current 4BASEBIO UK SOCIETAS drawdown is 14.29%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-47.71%Sep 30, 2021196Jul 13, 2022410Feb 27, 2024606
-31.11%Feb 22, 202115Mar 12, 202171Jun 25, 202186
-15.38%Jun 19, 20248Jun 28, 2024
-9.72%Sep 2, 202110Sep 15, 202110Sep 29, 202120
-9.44%Aug 10, 20216Aug 17, 20219Aug 31, 202115

Volatility

Volatility Chart

The current 4BASEBIO UK SOCIETAS volatility is 18.58%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%20.00%FebruaryMarchAprilMayJuneJuly
18.58%
2.26%
4BB.L (4BASEBIO UK SOCIETAS)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of 4BASEBIO UK SOCIETAS over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

P/E Ratio

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for 4BASEBIO UK SOCIETAS.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items